
S13 Ep42: Endometrial (Uterine) Cancer 2025 UPDATE
OncLive® On Air
00:00
New Evidence for Doxorubicin Plus Trabectedin
Sam summarizes the LMS04 trial showing improved overall survival with doxorubicin plus trabectedin for leiomyosarcoma.
Play episode from 09:26
Transcript


